Zydus Lifesciences Extends Sunshine Healthcare JV Investment Deadline to 2026
Zydus Lifesciences has extended the investment deadline for its 50:50 joint venture with Sunshine Healthcare Lanka to December 2026. This extension allows more time for the partners to complete their planned investments and collaborations under the joint venture agreement.
Sahi·



